Pharma-Bio Serv, Inc.
PBSV
$0.42
-$0.16-27.16%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 144.23% | 287.06% | -100.62% | 33.93% | 144.62% |
| Total Depreciation and Amortization | -77.63% | -12.99% | 27.31% | 31.31% | 36.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.38% | 35.72% | 295.34% | -28.25% | 522.52% |
| Change in Net Operating Assets | -23.06% | -6.55% | 398.25% | 231.74% | 3.04% |
| Cash from Operations | -21.12% | 9.17% | 256.76% | 135.28% | 56.96% |
| Capital Expenditure | 46.51% | -- | 99.75% | -5.26% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.51% | 179.49% | -360.67% | -55.83% | -602.24% |
| Cash from Investing | 41.52% | 179.95% | -599.53% | -55.86% | -603.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 95.93% | -- | -- | -194.12% | -647.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.13% | -- | -- | -- | 0.13% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.09% | -- | -- | -194.12% | -0.73% |
| Foreign Exchange rate Adjustments | -102.72% | 149.74% | 375.00% | 161.97% | 358.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.82% | 341.72% | -334.02% | -38.07% | -79.54% |